Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

Insiders Menu
Roster
Transactions
Acrivon Therapeutics, Inc.

DateNameTitleTypeSecuritySharesPriceValueOwnershipReported
09/26/2023Miller MaryChief Legal OfficerGrantStock Option (Right to Buy)11.6k$8.95$103.6k 09/26/2023
09/26/2023Miller MaryChief Legal OfficerGrantCommon Stock3.9k$0.00$0 09/26/2023
08/21/2023Blume-Jensen PeterPresident and CEOGrantCommon Stock494k$0.00$0 08/21/2023
06/26/2023Chione Ltd10% OwnerSaleCommon Stock16$12.93$206.9 06/26/2023
06/22/2023BAUM CHARLES MDirectorGrantStock Option (Right to Buy)32.5k$12.88$418.6k 06/22/2023
06/05/2023Devroe EricCOOExerciseStock Option (Right to Buy)9.2k$1.04$9.6k 06/05/2023
05/31/2023Blume-Jensen PeterPresident and CEOExerciseStock Option (Right to Buy)33.6k$3.88$130.4k 05/31/2023
11/17/2022Chione Ltd10% OwnerPurchaseCommon Stock400k$12.50$5M 11/17/2022
11/17/2022Chione Ltd10% OwnerConversionCommon Stock3.4M$0.00$0 11/17/2022
11/17/2022Chione Ltd10% OwnerConversionCommon Stock10.7k$0.00$0 11/17/2022
11/17/2022Chione Ltd10% OwnerConversionSeries A-1 Preferred Stock8.5M$0.00$0 11/17/2022
11/17/2022Chione Ltd10% OwnerConversionSeries B Preferred Stock26.3k$0.00$0 11/17/2022
11/17/2022Wellington Biomedical Innovation Master Investors (Cayman) I L.P.10% OwnerConversionSeries B Preferred Stock2.2M$0.00$0 11/17/2022
11/17/2022Wellington Biomedical Innovation Master Investors (Cayman) I L.P.10% OwnerConversionCommon Stock888.1k$0.00$0 11/17/2022
11/17/2022RA CAPITAL MANAGEMENT, L.P.10% OwnerConversionCommon Stock994.7k$0.00$0See Footnotes11/17/2022
11/17/2022RA CAPITAL MANAGEMENT, L.P.10% OwnerPurchaseCommon Stock3.4M$12.50$42.4MSee Footnotes11/17/2022
11/17/2022RA CAPITAL MANAGEMENT, L.P.10% OwnerConversionCommon Stock426.3k$0.00$0See Footnotes11/17/2022
11/17/2022RA CAPITAL MANAGEMENT, L.P.10% OwnerConversionSeries B Preferred Stock2.5M$0.00$0See footnotes11/17/2022
11/17/2022RA CAPITAL MANAGEMENT, L.P.10% OwnerConversionSeries B Preferred Stock1.1M$0.00$0See footnotes11/17/2022
11/14/2022DiRocco DerekDirectorGrantStock Option (Right to Buy)35.2k$12.50$440.4k 11/14/2022
11/14/2022Blume-Jensen PeterPresident and CEOGrantCommon Stock60.1k$0.00$0 11/14/2022
11/14/2022Blume-Jensen PeterPresident and CEOGrantCommon Stock503.4k$0.00$0 11/14/2022
11/14/2022TOMSICEK MICHAEL JOHNDirectorGrantStock Option (Right to Buy)35.2k$12.50$440.4k 11/14/2022
11/14/2022Blume-Jensen PeterPresident and CEOGrantCommon Stock26.7k$0.00$0See footnote11/14/2022
11/14/2022Gamelin ErickChief Medical OfficerGrantCommon Stock20k$0.00$0 11/14/2022
11/14/2022Gamelin ErickChief Medical OfficerGrantStock Option (Right to Buy)60.1k$12.50$751.1k 11/14/2022
11/14/2022Shacham SharonDirectorGrantStock Option (Right to Buy)35.2k$12.50$440.4k 11/14/2022
11/14/2022RA CAPITAL MANAGEMENT, L.P.10% OwnerGrantStock Option (Right to Buy)35.2k$12.50$440.4kSee footnotes11/14/2022
11/14/2022Blume-Jensen PeterPresident and CEOGrantStock Option (Right to Buy)180.3k$12.50$2.3M 11/14/2022
11/14/2022Blume-Jensen PeterPresident and CEOGrantStock Option (Right to Buy)80.1k$12.50$1MSee footnote11/14/2022
11/14/2022Holm-Jorgensen RasmusCFOGrantCommon Stock20k$0.00$0 11/14/2022
11/14/2022Holm-Jorgensen RasmusCFOGrantStock Option (Right to Buy)60.1k$12.50$751.1k 11/14/2022
11/14/2022Masson KristinaEVP - Business OperationsGrantCommon Stock26.7k$0.00$0 11/14/2022
11/14/2022Masson KristinaEVP - Business OperationsGrantCommon Stock934.7k$0.00$0See footnote11/14/2022
11/14/2022Masson KristinaEVP - Business OperationsGrantCommon Stock503.4k$0.00$0See footnote11/14/2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy